Search research articles
Contact Us
Filters
Showing results (21-30 of 24) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 24 results.
Blood Advances
|
August 26, 2022
Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma
Tarek H Mouhieddine, Oliver Van Oekelen, David T Melnekoff, et al.
JCI Insight
|
May 5, 2026
Detection of cytokine release syndrome using wearables and cytokine profiling following CAR-T therapy for myeloma
Sridevi Rajeeve, Matt Wilkes, Nicole Zahradka, et al.
Blood Advances
|
May 22, 2024
Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma
Mateo Mejia Saldarriaga, Darren Pan, Caitlin Unkenholz, et al.
Blood
|
August 1, 2025
Sequential Targeting in Multiple Myeloma: Talquetamab, a GPRC5D bispecific antibody, as a Bridge to BCMA CAR-T cell therapy
Binod Dhakal, Othman Salim Akhtar, David Fandrei, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 24) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 24 results.
Blood Advances
|
August 26, 2022
Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma
Tarek H Mouhieddine, Oliver Van Oekelen, David T Melnekoff, et al.
JCI Insight
|
May 5, 2026
Detection of cytokine release syndrome using wearables and cytokine profiling following CAR-T therapy for myeloma
Sridevi Rajeeve, Matt Wilkes, Nicole Zahradka, et al.
Blood Advances
|
May 22, 2024
Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma
Mateo Mejia Saldarriaga, Darren Pan, Caitlin Unkenholz, et al.
Blood
|
August 1, 2025
Sequential Targeting in Multiple Myeloma: Talquetamab, a GPRC5D bispecific antibody, as a Bridge to BCMA CAR-T cell therapy
Binod Dhakal, Othman Salim Akhtar, David Fandrei, et al.
Page
of 3